BRIEF published on 08/06/2026 at 07:50, 1 month 30 days ago Carvolix secures €30 million in funding to support its growth Structured Finance Carvolix Biomimetic Implants TAVIPILOT Claret Capital
BRIEF published on 08/06/2026 at 07:45, 1 month 30 days ago Leifheit AG Reports First Half of 2026 Figures with Focus on Competitiveness Profitability Leifheit AG Competitiveness FOCUS Program 2026 Financial Results
BRIEF published on 08/06/2026 at 07:45, 1 month 30 days ago Leifheit AG publie ses résultats du premier semestre 2026, axés sur la compétitivité. Rentabilité Leifheit AG Compétitivité Programme FOCUS Résultats Financiers 2026
BRIEF published on 08/06/2026 at 07:38, 1 month 30 days ago 1&1 Reports Half-Year Financial Performance Revenue Growth Financial Forecast EBITDA Increase Customer Contracts 1&1 AG Results
BRIEF published on 08/06/2026 at 07:38, 1 month 30 days ago 1&1 publie ses résultats financiers du premier semestre Prévisions Financières Croissance Des Revenus Augmentation De L'EBITDA Contrats Clients Résultats De 1&1 AG
BRIEF published on 08/06/2026 at 07:36, 1 month 30 days ago Henkel Reports Strong First Half Performance and Upgrades 2026 Outlook Sales Growth M&A Strategy Earnings Henkel 2026 Forecast
BRIEF published on 08/06/2026 at 07:36, 1 month 30 days ago Henkel annonce de solides résultats au premier semestre et revoit à la hausse ses perspectives pour 2026. Croissance Des Ventes Henkel Gains Stratégie De Fusions Et Acquisitions Prévisions Pour 2026
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Nordex Group Secures Significant 525 MW Order in Türkiye Renewable Energy Nordex Group Wind Turbines Türkiye Market Türkerler Holding
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Le groupe Nordex obtient une commande importante de 525 MW en Turquie Énergie Renouvelable Groupe Nordex Éoliennes Marché Turc Türkerler Holding
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Evotec and Odyssey Therapeutics Join Forces in AI-Driven Drug Discovery Evotec SE Inflammatory Diseases Autoimmune Diseases Odyssey Therapeutics AI-driven Discovery
Published on 10/05/2026 at 22:30, 4 hours 16 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 12 hours 1 minute ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 12 hours 16 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 12 hours 16 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 12 hours 46 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 22:25, 4 hours 21 minutes ago LumApps Named a Leader in 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Published on 10/05/2026 at 22:05, 4 hours 41 minutes ago AMPERA SUBMITS COMPREHENSIVE ENGAGEMENT PLAN TO THE U.S. NUCLEAR REGULATORY COMMISSION
Published on 10/05/2026 at 21:10, 5 hours 36 minutes ago Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 5 hours 40 minutes ago EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Published on 10/05/2026 at 20:15, 6 hours 31 minutes ago EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 22:12, 4 hours 34 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 4 hours 34 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 8 hours 33 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 8 hours 33 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 8 hours 46 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
